News Headlines

  1. Gannet BioChem Acquires Laysan Bio To Expand Activated Polymer And Bioconjugation Capabilities 1/22/2026

    Gannet BioChem, a leading specialty Contract Development and Manufacturing Organization (CDMO) backed by Boston-based private equity firm Ampersand Capital Partners, today announced the acquisition of Laysan Bio, a life sciences company based in Arab, Alabama.

  2. Cellular Origins, Fresenius Kabi Achieve First Milestone In Robotic Automation Designed To Scale Cell And Gene Therapy Manufacturing 1/22/2026

    Cellular Origins announced today they have successfully completed the first phase of their collaboration with Fresenius Kabi designed to help scale the manufacturing of cell and gene therapies using advanced robotics and cell processing technologies.

  3. HRV Pharma Partners With Haleos Labs To Accelerate Orphan And Niche API Development 1/22/2026

    HRV Pharma is pleased to announce a multi-year strategic partnership with Haleos Labs (formerly SMS LifeSciences) to develop and manufacture orphan and niche active pharmaceutical ingredients (APIs).

  4. Charles River Enters Manufacturing Collaboration With Gazi University 1/21/2026

    Charles River Laboratories International, Inc. and Gazi University Faculty of Medicine, today announced a gene therapy contract development and manufacturing organization (CDMO) collaboration, providing plasmid DNA for AAV production and in vitro efficacy studies.

  5. Otsuka And Towa Conclude Basic Agreement On The Succession And Manufacturing Outsourcing Of Long Listed Products, Establishing A Collaborative Framework For Stable Supply 1/21/2026

    Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Towa Pharmaceutical Co., Ltd. (Towa) are pleased to announce that the two companies have entered into an agreement to establish a strategic collaborative framework in pharmaceutical manufacturing.

  6. CDMO Alcami Expands RTP Footprint With New Durham Facility And Major Lab Expansion 1/20/2026

    Alcami Corporation, a leading U.S.-based contract development and manufacturing organization (CDMO), has acquired a 37,000-square-foot facility at 4620 Creekstone Drive in Durham, North Carolina. This $6.7 million investment strengthens Alcami's presence in the Research Triangle region and supports the company's continued expansion of advanced laboratory services.

  7. Insilico Medicine And Hygtia Therapeutics Enter New Global Strategic Collaboration To Co-Develop Novel Brain Penetrant NLRP3 Inhibitor For CNS Diseases treatment 1/20/2026

    Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), and Hygtia Therapeutics Co., Ltd., (Hygtia Therapeutics), today announced a co-development collaboration agreement for Insilico's ISM8969 program.

  8. GSK Enters Agreement To Acquire RAPT Therapeutics 1/20/2026

    GSK plc today announced that it has entered a definitive agreement to acquire RAPT Therapeutics (“RAPT”), a California-based, clinical-stage biopharmaceutical company dedicated to developing novel therapies for patients living with inflammatory and immunologic diseases.

  9. Alteogen Announces Exclusive License Agreement With Tesaro, A Subsidiary Of GSK, For The Development Of A Subcutaneous Formulation Of Dostarlimab Enabled By Hybrozyme™ Technology 1/20/2026

    Alteogen Inc. (KOSDAQ: 196170) announced today that the company has entered into an exclusive license agreement with Tesaro, Inc., a subsidiary of GSK. Under the terms of the agreement, Tesaro will acquire world-wide rights to use ALT-B4, Alteogen's novel hyaluronidase utilizing Hybrozyme™ technology, for the development and commercialization of a subcutaneous formulation of dostarlimab, a programmed death receptor-1 (PD-1) blocking antibody.

  10. ten23 health And BD Partner To Enable Supply Chain Readiness Of BD Libertas Wearable Injector As Full-Service Solution 1/20/2026

    ten23 health, the human-centric and sustainable strategic CDMO partner of choice for the pharmaceutical industry and biotech start-ups today announced a manufacturing collaboration to support the commercialization of the BD Libertas wearable injector.